TEOSYAL® PURESENSE ULTRA DEEP (2×1.2ml)

Product Information

• Active ingredient: Hyaluronic acid, lidocaine
• Strength: 25 mg/ml HA, 3 mg/ml lidocaine
• Package content: 2 x 1.2 ml pre-filled syringes, 2 x 25G 1″ needles
• Manufacturer: Teoxane
• Brand: TEOSYAL®
• Category: HA Dermal Fillers

Teosyal Puresense Ultra Deep (2 x 1.2ml) Main Ingredients and Device Properties

The main ingredient in Teosyal Puresense Ultra Deep is cross-linked hyaluronic acid of non-animal origin, known for its hydrating and volumising properties. The product also contains lidocaine to minimise discomfort during injection.

Its high viscoelasticity ensures optimal results in volumising and contouring treatments. Since the product comes in pre-filled syringes, it ensures that it’s sterile before use.

Package Contains

Each pack of Teosyal Puresense Ultra Deep (2 x 1.2ml) includes the following:

• Two pre-filled syringes of 1.2 ml each
• Two 25G 1” needles
• Package insert
• Traceability labels.

Storage Conditions

Proper storage of Teosyal Puresense Ultra Deep is crucial to maintain its effectiveness and safety. Ensure the following conditions are met:

• Store between 2°C and 25°C.
• Keep away from direct sunlight and heat.
• Do not freeze.
• Store in original packaging until use.

Mode of Administration

Administering Teosyal Puresense Ultra Deep involves several phases to ensure a safe and effective procedure:

Pre-procedure:

• Cleanse and disinfect the treatment area.
• Apply topical anaesthetic if necessary.
• Ensure the patient is informed about the procedure and potential side effects.

During procedure:

• Use the provided needles for injection.
• Inject slowly and steadily into the deep dermis or subcutaneous tissue.
• Massage the treated area gently to ensure even distribution.

After procedure:

• Apply a cold compress to reduce swelling.
• Provide the patient with post-treatment care instructions.

Post-Treatment Care

The following post-treatment care can help patients maintain the results for longer and minimise potential adverse reactions. Recommendations include:

• Avoid strenuous activities and exercise for 24 hours.
• Refrain from touching or massaging the treated area for the first 6 hours.
• Avoid excessive sun or heat exposure for a week.
• Use sunscreen with high SPF to protect the treated area.
• Stay hydrated and follow a healthy skincare routine.

Benefits and Results of Using Teosyal Puresense Ultra Deep (2 x 1.2ml)

Deciding on Teosyal Puresense Ultra Deep offers numerous benefits, including:

• Immediate volume restoration
• Smooths deep wrinkles and folds
• Enhances facial contours
• Long-lasting results
• Contains lidocaine for reduced treatment pain
• High patient satisfaction.

Potential Side Effects

Like with all medical devices, the application of Teosyal dermal fillers can lead to potential side effects:

• Common: Redness, swelling, bruising, tenderness at the injection site
• Rare: Allergic reactions, infection, nodules or granulomas, vascular occlusion.

Contraindications for the Treatment

Teosyal Puresense Ultra Deep should not be used in the following cases:

• Known hypersensitivity to hyaluronic acid or lidocaine
• Patients with autoimmune disorders
• Pregnant or breastfeeding women
• Patients on anticoagulant medication or with blood disorders
• Areas with active skin infections or inflammations
• Patients prone to hypertrophic scarring or keloids.

Buying TEOSYAL® PURESENSE ULTRA DEEP (2×1.2ml) in Canada

Kinami Health supplies genuine TEOSYAL® PURESENSE ULTRA DEEP (2×1.2ml) to licensed healthcare professionals and clinics across Canada, sourced through verified channels and delivered in sealed original packaging with a traceable LOT number, with wholesale pricing and fast delivery.

In Canada, who may administer dermal filler injections varies by province and professional college; practitioners should follow the rules that apply in their own jurisdiction. Adverse reactions can be reported to Health Canada.

Explore the full TEOSYAL® range or compare other products in the HA Dermal Fillers category.